Nephropathy of cyanotic congenital heart disease: Clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor

Clinical Nephrology

Volumn 58, Issue 2, 2002, Pages 95-102

  Fujimoto, Y ^a   Matsushima, M ^a   Tsuzuki, K ^a   Okada, M ^a   Shibata, M ^a   Yanase, Y ^a   Usui, K ^a   Nagashima, M ^a  

^a CHUKYO HOSPITAL   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Cyanotic congenital heart disease; Nephrotic syndrome; Proteinuria; Renal disease

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PROTEIN; ALPHA N ACETYLGALACTOSAMINIDASE; BETA 2 MICROGLOBULIN; BETA N ACETYLHEXOSAMINIDASE; BIOLOGICAL MARKER; CREATININE; NAGA PROTEIN, HUMAN; SERUM ALBUMIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DRUG EFFICACY; DRUG INDICATION; DRUG USE; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEMATEMESIS; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; PROTEINURIA; TREATMENT OUTCOME; URINARY EXCRETION; BIOPSY; BLOOD; COMPARATIVE STUDY; CONGENITAL HEART MALFORMATION; DRUG EFFECT; EVALUATION; JAPAN; KIDNEY; KIDNEY FUNCTION TEST; NEPHROTIC SYNDROME; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE;

ADOLESCENT; ADULT; ALPHA-N-ACETYLGALACTOSAMINIDASE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BIOPSY; BLOOD PRESSURE; CHILD; CREATININE; ENALAPRIL; FEMALE; GLOMERULAR FILTRATION RATE; HEART DEFECTS, CONGENITAL; HEXOSAMINIDASES; HUMANS; JAPAN; KIDNEY; KIDNEY FUNCTION TESTS; MALE; NEPHROTIC SYNDROME; PROTEINURIA; RENAL PLASMA FLOW; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 0036023010     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp58095     Document Type: Article

References (33)

1. Renal function of Fallot's Tetralogy
2. Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin
3. The hyperfiltration theory: A paradigm shift in nephrology
4. A quantitative study of glomerular enlargement in children with tetralogy of Fallot
5. Mechanism of angiotensin II-induced proteinuria in the rat
6. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease
7. The role of proteinuria in the progression of chronic renal failure
8. A comparison of enalapril with hydralazine-isosorbide in the treatment of chronic congestive heart failure
9. The effect of phlebotomy on renal function and proteinuria in a patient with congenital cyanotic heart disease
10. Renal impairment in patients with long-standing cyanotic congenital heart disease
11. Incidence of renal dysfunction in adults with cyanotic congenital heart disease
12. 99Tc-DTPA
13. Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease
14. Effect of captopril on intrarenal blood flow
15. Glomerulomegaly in a patient with cyanotic congenital heart disease
16. Angiotensin II stimulates extracellular matrix protein synthesis though induction of transforming growth factors-β expression in rat glomerular mesangial cells
17. Renal involvement in patients with congenital cyanotic heart disease
18. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
19. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy
20. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat
21. Plasma levels of atrial natriuretic factor in patients with congestive heart failure
22. Angiotensin II: Renal localization in glomerular mesangial cells by autoradiography
23. Abnormal renal functions in cyanotic congenital heart disease
24. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria
25. Angiotensin-converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy
26. Renal function and urate metabolism in late survivors with cyanotic congenital heart disease
27. Increased glomerular capillary pressure alters glomerular cytokine expression
28. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: A multicenter trial including 1141 subjects
29. The glomerular lesion of cyanotic congenital heart disease
30. 131 I-orthoiodohippurate
31. Angiotensin converting enzyme inhibitor improves nephrotic syndrome associated with cyanotic congenital heart disease
32. Renal function in patients with chronic hypoxemia and cor pulmonale following reversal of polycythemia
33. Molecular mechanisms of angiotensin II in the kidney: Emerging role in the progression of renal disease: Beyond hemodynamics